Cardiff Oncology Inc
Ownership
Ownership Structure
Who owns Cardiff Oncology Inc (CRDF)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 96.9% of the shares are freely tradable; institutional investors hold 32.8%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| LAURION CAPITAL MANAGEMENT LP | 3.98 | 3,098,299 | +17.1 | 06/30/2026 |
| Vanguard Capital Management, LLC | 3.72 | 2,895,592 | +1.4 | 06/30/2026 |
| Pfizer Inc | 3.10 | 2,411,575 | +0.0 | 06/30/2026 |
| Franklin Templeton Inc | 1.55 | 1,205,803 | +0.0 | 06/30/2026 |
| BlackRock Inc | 1.25 | 972,873 | -75.6 | 06/30/2026 |
| Blair William & Co | 1.17 | 912,513 | -1.1 | 06/30/2026 |
| Geode Capital Management, LLC | 1.05 | 820,062 | -48.7 | 06/30/2026 |
| UBS Group AG | 0.82 | 638,699 | +59.4 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 2.66 | 2,073,126 | +0.0 | 09/30/2026 |
| Franklin Biotechnology Discv A(acc)USD | 0.99 | 766,685 | +0.0 | 09/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Pace Gary W | Director | 2,043,661 | 1,818,041 $ | Jul 14, 2026 | direct |
| Mohindru Mani | Chief Executive Officer | 59,067 | 52,546 $ | Jul 14, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 14, 2026 | Pace Gary W | Director | Buy | 687,285 | 1.46 | 1,000,000 |
| Jul 14, 2026 | Mohindru Mani | Chief Executive Officer | Buy | 34,364 | 1.46 | 50,000 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.